improving user experience . read our cookie policy for more information . click here to accept the use of cookies on our website . home careers contact us print about us company overview strategy our vision senior leadership board of directors history product pipeline products in development ofatumumab daratumumab tisotumab vedotin teprotumumab humax tac adc humax il8 jnj 61178104 jnj 61186372 jnj 63709178 amg 714 pre clinical clinical trials research and technology introduction to antibodies genmab antibody discovery genmab technology virtual lab tour partnering our approach current partnerships licensing opportunities technology products investors media contact us office locations contact form careers our culture meet the team benefits current vacancies genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer . 2016 capital markets day genmab will host a capital markets day on november 10 2016 at the four seasons hotel in new york . the meeting will feature a variety of genmab speakers who will provide updates on our business including the clinical and pre clinical pipelines proprietary next generation antibody technologies and r & d capabilities . click here for more information and to register for the event . this meeting will be webcast live and details on how to join the webcast will be available on www.genmab.com . our technologies explained visit genmabtech.com to learn about genmab s innovative proprietary technologies ; the duobody and hexabody platforms . virtual lab tour watch our new virtual lab tour to learn more about genmab s research and development capabilities and our proprietary duobody and hexabody technologies . latest news u.s. fda grants priority review for daratumumab in relapsed multiple myeloma data from the phase iii study of daratumumab published in the new england journal of medicine genmab s financial calendar for 2017 major shareholder announcement more genmab news releases our strategy click here to watch a video about our strategy . stock info about us product pipeline partnering research and technology investors media careers contact us accessibility policy cookie policy disclaimer sitemap 2016 genmab a s